Sarepta Therapeutics, Inc. (SRPT) › Net IncomeSarepta Therapeutics, Inc. (SRPT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$25.16M2010: -$32.18M2011: -$2.32M2012: -$121.29M2013: -$111.98M2014: -$135.79M2015: -$220.03M2016: -$267.26M2017: -$50.69M2018: -$361.92M2019: -$715.08M2020: -$554.13M2021: -$418.78M2022: -$703.49M2023: -$535.98M2024: $235.24M2025: -$713.41M-$713.41M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$713.41M-403.3%2024$235.24M+143.9%2023-$535.98M+23.8%2022-$703.49M-68.0%2021-$418.78M+24.4%2020-$554.13M+22.5%2019-$715.08M-97.6%2018-$361.92M-614.0%2017-$50.69M+81.0%2016-$267.26M-21.5%2015-$220.03M-62.0%2014-$135.79M-21.3%2013-$111.98M+7.7%2012-$121.29M-5132.4%2011-$2.32M+92.8%2010-$32.18M-27.9%2009-$25.16M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share